Concepedia

47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01

Michele Droz Dit Busset, Walid L. Shaib, Kabir Mody, Nicola Personeni, Nevena Damjanov, William Proctor Harris, Francesca Bergamo, Giovanni Brandi, Gianluca Masi, T.R. Halfdanarson,

Annals of Oncology · 2021 · 20 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyMolecular OncologyNeoplasiaPrecision OncologyBiliary Tract CancerGene Fusions In CancerLiver CancerMolecular Tumor ProfilingTargeted Cancer TherapyTargeted TherapyCholangiocarcinoma PharmacotherapyFgfr Fusion GenesHepatic TumorsIntrahepatic Cholangiocarcinoma SurgeryLiver Tumor TherapyOncogenic Fusion ProteinsSolid Tumor Fusion Genes